Home > Publications > Articles > Hall and Schwab publish article in Health Lawyers Weekly

Hall and Schwab publish article in Health Lawyers Weekly

Posted:
10/19/2012
Services:
Commercial Litigation, Corporate Governance, White Collar and Government Enforcement
Industries:
Health Care, Life Sciences, Government Contracts

D.C. Circuit Affirms Exclusion From Federal Healthcare Programs Under “Responsible Corporate Officer” Doctrine – With A Twist

Christopher R. Hall, chair of the White Collar and Government Enforcement Practice, and Gregory G. Schwab, an associate in the same Practice, wrote this article that was published in Health Lawyers Weekly. It deals with the government’s power to exclude pharmaceutical executives from participating in federal health care programs if they fail to prevent fraudulent misbranding of their products, even if they did not personally commit or condone the conduct.

The article documents recent developments in a case involving Purdue Frederick, Co., executives and the misbranding of OxyContin and explains why the government’s victory in the case was not absolute.